Kaiser Permanente and Union Reach Tentative Deal After Largest US Healthcare Strike
![Kaiser Permanente and Union Reach Tentative Deal After Largest US Healthcare Strike](https://globalhealthcareoutlook.com/wp-content/uploads/2023/10/Kaiser_Permanente_Tentative_deal_after_largest_US_healthcare_strike.png)
October 20, 2023 : Kaiser Permanente and the Coalition of Kaiser Permanente Unions (CKPU) have reached a tentative agreement after the largest healthcare strike in US history. The strike, involving over 75,000 workers, lasted three days and ended on October 7, 2023.
Centhaquine to Enter US-FDA Approved Phase 3 Clinical Trial in US and Europe
![Centhaquine to Enter US-FDA Approved Phase 3 Clinical Trial in US and Europe](https://globalhealthcareoutlook.com/wp-content/uploads/2023/10/Centhaquine_set_to_enter_US_FDA_approved_Phase_3_Clinical_Trial.png)
October 20, 2023 : Centhaquine, a novel drug candidate for treating Alzheimer’s disease (AD), is set to enter a Phase 3 clinical trial in the US and Europe. The trial has been approved by the US Food and Drug Administration (FDA).